(RTTNews) - Picard Medical, Inc. (PMI) reported Loss for its second quarter of -$7.520 million
The company's earnings totaled -$7.520 million, or -$0.85 per share. This compares with -$4.721 million, or -$0.59 per share, last year.
The company's revenue for the period rose 207.1% to $2.131 million from $0.694 million last year.
Picard Medical, Inc. earnings at a glance (GAAP) :
-Earnings: -$7.520 Mln. vs. -$4.721 Mln. last year. -EPS: -$0.85 vs. -$0.59 last year. -Revenue: $2.131 Mln vs. $0.694 Mln last year.
Patrick NJ Schnegelsberg, CEO of Picard Medical, said: “Our second quarter results reflect strong sales growth for the SynCardia total artificial heart. We achieved over 200% revenue growth year-over-year, strengthened our operating profile, and successfully completed our IPO the proceeds of which provide us with the capital to advance development of our next-generation fully implantable heart and expand access to the SynCardia platform globally.”
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
